30 Apr 2026
In an interview with Barron’s, Labcorp CEO Adam Schechter discussed the company’s strong first quarter of 2026. The company beat earnings expectations and raised its full year outlook, reflecting solid performance driven by demand across the company’s diagnostics portfolio and continued momentum in both Diagnostics and Biopharma Laboratory Services.
Schechter emphasized that AI, automation and robotics are core to Labcorp’s strategy and future growth. He noted the company has changed its mindset to a “technology‑first approach,” using technology across its operations to improve efficiency and scale. Read the full article on Barron’s to learn more.